Hyundai Bioscience

048410.KQ

3.56 USD

0.00

0.00%

Overview

Last close

3.56 usd

Market cap

341.68M usd

52 week high

7.58 usd

52 week low

3.13 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

257.6976

Price/Book Value

4.5806

Enterprise Value

322.49M usd

EV/Revenue

242.721

EV/EBITDA

-64.6317

Key financials

Revenue TTM

1.33M usd

Gross Profit TTM

55132.76 usd

EBITDA TTM

-10.42M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

83.26M usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.